Search alternatives:
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
marked decrease » marked increase (Expand Search)
harm reported » data reported (Expand Search), aes reported (Expand Search), were reported (Expand Search)
Showing 1 - 20 results of 2,845 for search '(( harm reported decrease ) OR ( a ((larger decrease) OR (marked decrease)) ))', query time: 0.46s Refine Results
  1. 1
    (A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.

    (A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade.

    Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade.

    Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade.

    Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes.

    Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    PGx (number and percentage) associated adverse drug reactions and the prescribing prevalence (number and percentage) over a 20-year period (1993–2013).

    PGx (number and percentage) associated adverse drug reactions and the prescribing prevalence (number and percentage) over a 20-year period (1993–2013). by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients.

    Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

    Published 2025
    “…This decrease was larger in the disconnected than in the contralateral cortex. …”
    Save to List
    Saved in:
  9. 9
    A typical metaboliser prevalence for CYP2D6 and CYP2C19 across diverse ancestry groups. These are genetically predicted based on data published by PharmGKB and CPIC. We have defined atypical metabolisers as the following: poor (activity score 0 for 2D6), intermediate (activity score <1 for 2D6), and ultrarapid metabolisers (activity score >2 for 2D6).

    A typical metaboliser prevalence for CYP2D6 and CYP2C19 across diverse ancestry groups. These are genetically predicted based on data published by PharmGKB and CPIC. We have define... by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Map of Pakistan with marked Punjab province.

    Map of Pakistan with marked Punjab province. by Sumaira Sumaira (21453523)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Biases in larger populations.

    Biases in larger populations. by Sander W. Keemink (21253563)

    Published 2025
    “…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
    Save to List
    Saved in:
  12. 12
    The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT).

    The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

    Published 2025
    Save to List
    Saved in:
  13. 13
    PLB is a target gene of miRNA 221.

    PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

    Published 2025
    Save to List
    Saved in:
  14. 14
    Proportion of ADRs per drug compared with prescribing prevalence.

    Proportion of ADRs per drug compared with prescribing prevalence. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Percentage of PGx mitigatable ADRs by prescriber specialty.

    Percentage of PGx mitigatable ADRs by prescriber specialty. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Percentage of adverse drug reactions (ADRs) for pharmacogene-associated medications.

    Percentage of adverse drug reactions (ADRs) for pharmacogene-associated medications. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Percentage of ADR reports for PGx drugs and associated genes by decade.

    Percentage of ADR reports for PGx drugs and associated genes by decade. by Emma F. Magavern (20947928)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Quadratic inverse U-shape relationship between Moral Behavior during the pandemic and Instrumental Harm subscale.

    Quadratic inverse U-shape relationship between Moral Behavior during the pandemic and Instrumental Harm subscale. by Aistė Ambrasė (22505574)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Association between sociodemographic characteristics and reported safeguarding concerns in under 16 year olds with one or more alcohol-related attendance between 2011 and 2022.

    Association between sociodemographic characteristics and reported safeguarding concerns in under 16 year olds with one or more alcohol-related attendance between 2011 and 2022. by Nicholas Davies (367476)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Expression of lipid biosynthetic genes is decreased with polyamine depletion.

    Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

    Published 2024
    Save to List
    Saved in:

Search Tools: